Cargando…
Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review
BACKGROUND: Many clinical trials testing Ginkgo biloba extract EGb 761 in patients with mild forms of cognitive impairment were conducted before widely accepted terms and diagnostic criteria for such conditions were available. This makes it difficult to compare any results from earlier and more rece...
Autores principales: | Hort, Jakub, Duning, Thomas, Hoerr, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041984/ https://www.ncbi.nlm.nih.gov/pubmed/36994422 http://dx.doi.org/10.2147/NDT.S401231 |
Ejemplares similares
-
Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761(®))
por: Tomino, Carlo, et al.
Publicado: (2021) -
The Effect of Ginkgo Biloba (EGb 761) on Epileptic Activity in Rabbits
por: Ivetic, Vesna, et al.
Publicado: (2008) -
Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing Efficacy and Safety of Ginkgo biloba Extract EGb 761 and Betahistine
por: Sokolova, Larysa, et al.
Publicado: (2014) -
Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761(®). Findings from a randomized controlled trial
por: Bachinskaya, Natalia, et al.
Publicado: (2011) -
Strategies for the use of Ginkgo biloba extract, EGb 761(®), in the treatment and management of mild cognitive impairment in Asia: Expert consensus
por: Kandiah, Nagaendran, et al.
Publicado: (2020)